RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial

Cancer Patients ◽

Liquid Biopsy ◽

First Line ◽

Liquid biopsy to predict benefit from rechallenge with cetuximab (cet) + irinotecan (iri) in RAS/BRAF wild-type metastatic colorectal cancer patients (pts) with acquired resistance to first-line cet+iri: Final results and translational analyses of the CRICKET study by GONO.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.12007 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 12007-12007 ◽

Cited By ~ 7

Author(s):

Daniele Rossini ◽

Chiara Cremolini ◽

Elena Conca ◽

Marzia Del Re ◽

Adele Busico ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Liquid Biopsy ◽

Acquired Resistance ◽

Wild Type ◽

First Line ◽

Faculty Opinions recommendation of Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726943980.793538773 ◽

2017 ◽

Author(s):

Noelle LoConte ◽

Kieran Sahasrabudhe

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Iii ◽

First Line ◽

Phase Iii Study ◽

Line Chemotherapy

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component

Cancer Medicine ◽

10.1002/cam4.3876 ◽

2021 ◽

Author(s):

Yu‐Wen Zhou ◽

Yi‐Xiu Long ◽

Ye Chen ◽

Ji‐Yan Liu ◽

Dan Pu ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Mucinous Adenocarcinoma ◽

First Line ◽

First Line Therapy ◽

Mucinous Component ◽

Line Therapy ◽

CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies

British Journal of Cancer ◽

10.1038/s41416-021-01483-x ◽

2021 ◽

Author(s):

Roberto Moretto ◽

Daniele Rossini ◽

Veronica Conca ◽

Sara Lonardi ◽

Cosimo Rasola ◽

...

Keyword(s):

Colorectal Cancer ◽

Disease Progression ◽

Cancer Patients ◽

Induction Therapy ◽

Pooled Analysis ◽

First Line ◽

Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis

Annals of Oncology ◽

10.1093/annonc/mdy281.038 ◽

2018 ◽

Vol 29 ◽

pp. viii165

Author(s):

T. Buchler ◽

O. Fiala ◽

V. Veskrnova ◽

R. Chloupkova ◽

A. Poprach ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Cancer Patients ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

First-Line Systemic Chemotherapy with Folfoxiri Followed by Radical Surgical Resection of Metastases for the Treatment of Unresectable Metastatic Colorectal Cancer Patients

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy ◽

10.1007/978-1-60327-459-3_32 ◽

2009 ◽

pp. 285-293

Author(s):

Enrico Vasile ◽

Gianluca Masi ◽

Fotios Loupakis ◽

Samanta Cupini ◽

Giacomo Giulio Baldi ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Surgical Resection ◽

Systemic Chemotherapy ◽

First Line ◽

Resection Of Metastases ◽

Unresectable Metastatic Colorectal Cancer

Radical Surgical Resection ◽

Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients

Scientific Reports ◽

10.1038/s41598-020-60212-1 ◽

2020 ◽

Vol 10 (1) ◽

Cited By ~ 7

Author(s):

Diego de Miguel Pérez ◽

Alba Rodriguez Martínez ◽

Alba Ortigosa Palomo ◽

Mayte Delgado Ureña ◽

Jose Luis Garcia Puche ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Liquid Biopsy ◽

Extracellular Vesicle ◽

Disease Identification ◽

Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

Annals of Oncology ◽

10.1093/annonc/mdw335.14 ◽

2016 ◽

Vol 27 ◽

pp. iv43

Author(s):

D. Rossini ◽

M. Casagrande ◽

R. Moretto ◽

F. Loupakis ◽

C. Cremolini ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Line Treatment ◽

Targeted Agents ◽

First Line ◽

Safety And Efficacy ◽

First Line Treatment

P-0262 Prospective Evaluation of Candidate Snps of Vegf/Vegfr Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line Folfiri Plus Bevacizumab (BV)

Annals of Oncology ◽

10.1016/s0923-7534(20)30192-7 ◽

2012 ◽

Vol 23 ◽

pp. iv105-iv106

Author(s):

Chiara Cremolini ◽

Fotios Loupakis ◽

Dongyun Yang ◽

Lisa Salvatore ◽

Wu Zhang ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Candidate Snps ◽

Prospective Evaluation ◽

First Line ◽

Genetic variants in the Folic acid Metabolic Pathway Genes predict outcomes of metastatic Colorectal Cancer patients receiving first-line Chemotherapy

Journal of Cancer ◽

10.7150/jca.44580 ◽

2020 ◽

Vol 11 (22) ◽

pp. 6507-6515

Author(s):

Lu Jiang ◽

Shuwei Li ◽

Ming Yuan ◽

Ling Ma ◽

Yu Lin ◽

...

Keyword(s):

Colorectal Cancer ◽

Folic Acid ◽

Cancer Patients ◽

Metabolic Pathway ◽

Genetic Variants ◽

First Line ◽

Line Chemotherapy